Considering the mechanism by which droplets of ALS-FTD-associated SQSTM1/p62 mutants cause pathology

Large numbers of point mutations in SQSTM1/p62 have been identified in amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD). SQSTM1 interacts with ubiquitinated proteins, undergoing liquid-liquid phase separation, and the resulting SQSTM1-droplets are degraded by macroautophagy/...

Full description

Bibliographic Details
Main Authors: Yoshinobu Ichimura, Masaaki Komatsu
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Autophagy Reports
Subjects:
Online Access:http://dx.doi.org/10.1080/27694127.2022.2031380
_version_ 1797685783514054656
author Yoshinobu Ichimura
Masaaki Komatsu
author_facet Yoshinobu Ichimura
Masaaki Komatsu
author_sort Yoshinobu Ichimura
collection DOAJ
description Large numbers of point mutations in SQSTM1/p62 have been identified in amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD). SQSTM1 interacts with ubiquitinated proteins, undergoing liquid-liquid phase separation, and the resulting SQSTM1-droplets are degraded by macroautophagy/autophagy. SQSTM1 also serves as a multiple signaling hub for processes including selective autophagy and the anti-oxidative stress response. Such diverse functions are modulated by multiple domains and regions throughout the protein. Because mutations in SQSTM1 have been identified throughout its gene, including regions encoding the domains and motifs, the effects of these mutations on disease onset have been thought to be complicated. Recently, we thoroughly investigated how 7 mutations around the LC3-interacting region and KEAP1-interacting region (amino acids 335-356) affected autophagic degradation of SQSTM1, the anti-oxidative stress response, the KEAP1-NFE2L2/Nrf2 pathway, and the dynamics of SQSTM1 droplets. We found that reduced inner fluidity of the droplets is a unique, shared defect among all mutants, suggesting a link between qualitative changes in SQSTM1 liquid droplets and ALS-FTD. In this punctum article, we discuss the mechanism whereby reduced inner fluidity of mutant SQSTM1 droplets causes ALS-FTD pathology.
first_indexed 2024-03-12T00:56:22Z
format Article
id doaj.art-90a85eb69ffb40068b9a93f2cb6fb77b
institution Directory Open Access Journal
issn 2769-4127
language English
last_indexed 2024-03-12T00:56:22Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Autophagy Reports
spelling doaj.art-90a85eb69ffb40068b9a93f2cb6fb77b2023-09-14T13:24:39ZengTaylor & Francis GroupAutophagy Reports2769-41272022-12-011191310.1080/27694127.2022.20313802031380Considering the mechanism by which droplets of ALS-FTD-associated SQSTM1/p62 mutants cause pathologyYoshinobu Ichimura0Masaaki Komatsu1Juntendo University Graduate School of MedicineJuntendo University Graduate School of MedicineLarge numbers of point mutations in SQSTM1/p62 have been identified in amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD). SQSTM1 interacts with ubiquitinated proteins, undergoing liquid-liquid phase separation, and the resulting SQSTM1-droplets are degraded by macroautophagy/autophagy. SQSTM1 also serves as a multiple signaling hub for processes including selective autophagy and the anti-oxidative stress response. Such diverse functions are modulated by multiple domains and regions throughout the protein. Because mutations in SQSTM1 have been identified throughout its gene, including regions encoding the domains and motifs, the effects of these mutations on disease onset have been thought to be complicated. Recently, we thoroughly investigated how 7 mutations around the LC3-interacting region and KEAP1-interacting region (amino acids 335-356) affected autophagic degradation of SQSTM1, the anti-oxidative stress response, the KEAP1-NFE2L2/Nrf2 pathway, and the dynamics of SQSTM1 droplets. We found that reduced inner fluidity of the droplets is a unique, shared defect among all mutants, suggesting a link between qualitative changes in SQSTM1 liquid droplets and ALS-FTD. In this punctum article, we discuss the mechanism whereby reduced inner fluidity of mutant SQSTM1 droplets causes ALS-FTD pathology.http://dx.doi.org/10.1080/27694127.2022.2031380amyotrophic lateral sclerosisautophagyliquid dropletnrf2p62
spellingShingle Yoshinobu Ichimura
Masaaki Komatsu
Considering the mechanism by which droplets of ALS-FTD-associated SQSTM1/p62 mutants cause pathology
Autophagy Reports
amyotrophic lateral sclerosis
autophagy
liquid droplet
nrf2
p62
title Considering the mechanism by which droplets of ALS-FTD-associated SQSTM1/p62 mutants cause pathology
title_full Considering the mechanism by which droplets of ALS-FTD-associated SQSTM1/p62 mutants cause pathology
title_fullStr Considering the mechanism by which droplets of ALS-FTD-associated SQSTM1/p62 mutants cause pathology
title_full_unstemmed Considering the mechanism by which droplets of ALS-FTD-associated SQSTM1/p62 mutants cause pathology
title_short Considering the mechanism by which droplets of ALS-FTD-associated SQSTM1/p62 mutants cause pathology
title_sort considering the mechanism by which droplets of als ftd associated sqstm1 p62 mutants cause pathology
topic amyotrophic lateral sclerosis
autophagy
liquid droplet
nrf2
p62
url http://dx.doi.org/10.1080/27694127.2022.2031380
work_keys_str_mv AT yoshinobuichimura consideringthemechanismbywhichdropletsofalsftdassociatedsqstm1p62mutantscausepathology
AT masaakikomatsu consideringthemechanismbywhichdropletsofalsftdassociatedsqstm1p62mutantscausepathology